Carnegie has published a new commissioned research report on
To access the full report and subscribe to future updates, visit https://www.carnegie.se/en/commissioned-research/eql-pharma/
© Modular Finance, source
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
52.6 SEK | +0.77% | +4.78% | +57.49% |
12/06 | EQL Pharma Receives Approval for Listing to Nasdaq Stockholm Main Market | MT |
15/05 | Transcript : EQL Pharma AB, Q4 2024 Earnings Call, May 15, 2024 |
Carnegie has published a new commissioned research report on
To access the full report and subscribe to future updates, visit https://www.carnegie.se/en/commissioned-research/eql-pharma/
© Modular Finance, source
1st Jan change | Capi. | |
---|---|---|
+57.49% | 144M | |
-40.02% | 13.54B | |
-44.76% | 9.23B | |
-23.82% | 6.84B | |
-6.47% | 6.01B | |
+83.43% | 4.87B | |
-4.09% | 4.55B | |
+2.24% | 4.41B | |
-20.22% | 4.4B | |
-18.39% | 2.65B |